EN
Instrument Fundamentals
| Date | Close | Change | Change (%) | Open | High | Low |
|---|
News
A Look At Zai Lab (ZLAB) Valuation After New Amgen Oncology Collaboration News
Analysts' Top Healthcare Picks: Amgen (AMGN), Airsculpt Technologies (AIRS) | Markets Insider
Amgen Inc. $AMGN Position Boosted by JB Capital LLC
A Look At Amgen (AMGN) Valuation After New Repatha Data And Zai Lab Oncology Collaboration
Amgen Inc. (NASDAQ:AMGN) Receives $354.60 Consensus PT from Brokerages - Markets Daily
Thurston Springer Miller Herd & Titak Inc. Purchases 3,354 Shares of Amgen Inc. $AMGN - Stock Observer
Sheets Smith Wealth Management Sells 1,626 Shares of Amgen Inc. $AMGN - Stock Observer
Aberdeen Group plc Acquires 27,107 Shares of Amgen Inc. $AMGN
How Tavneos Safety Risks and New Oncology Pact Could Rebalance Amgen's (AMGN) Risk‑Reward Profile
Treatment monitoring by biomarker analysis in a Phase I dose-expansion study of AZD2811 for relapsed/refractory small-cell lung cancer
Is Amgen Inc. (AMGN) One of the Best Pharma Stocks to Invest in Now?
HF Advisory Group LLC Buys 7,548 Shares of Amgen Inc. $AMGN
Amgen synthesizes new GTPase KRAS (G12D mutant) inhibitors | BioWorld
Other news to note for April 2, 2026 | BioWorld
Semaglutide on liver fibrosis and heart outcomes in patients at high risk of liver fibrosis: a prespecified analysis of the SELECT randomized trial
Spatially resolved osteoblast-traced transcriptomics uncovers TGF-β as a combination target with sclerostin in osteoporosis
Nisa Investment Advisors LLC Has $55.22 Million Stake in Amgen Inc. $AMGN
Zai Lab Announces Global Clinical Trial Collaboration and Supply Agreement to Evaluate Novel DLL3 ADC, Zocilurtatug Pelitecan, in Combination with a Bispecific T-cell Engager Therapy
Amgen Inc. $AMGN Shares Sold by Meyer Handelman Co.
BTC Capital Management Inc. Sells 4,196 Shares of Amgen Inc. $AMGN
Amgen Inc. $AMGN Shares Acquired by Moody Lynn & Lieberson LLC - Stock Observer
US FDA warns of liver injuries, 8 deaths associated with Tavneos | BioWorld
5 Best Pharma Stocks to Invest In Now
US FDA warns of liver injury cases tied to Amgen's rare disease drug - Yahoo News Canada
Amgen's Tavneos Tied to Deaths, Liver Injury, FDA Says (1)
Amgen Inc. $AMGN Shares Purchased by Hofer & Associates. Inc
Amgen Inc. $AMGN is Hofer & Associates. Inc's 5th Largest Position - Daily Political
Mn Services Vermogensbeheer B.V. Acquires 3,327 Shares of Amgen Inc. $AMGN - Daily Political
AMGN: Obesity And Cardiovascular Pipeline Will Support Future Cash Generation
Amgen (AMGN) Stock Up Since Jim Cramer Said "You Could Do a Lot Worse Than Amgen"
This Top ETF Recently Added a Healthy Dose of These High-Yielding Dividend Stocks
Vantage Wealth Sells 1,700 Shares of Amgen Inc. $AMGN - Stock Observer
Quemliclustat and chemotherapy with or without zimberelimab in metastatic pancreatic adenocarcinoma: a randomized phase 1 trial
Global, regional and national burden of ischemic heart disease attributable to suboptimal diet, 1990-2023: a Global Burden of Disease study
Amgen announces data on Repatha from Phase 3 Vesalius-CV trial | Markets Insider
Amgen Inc. $AMGN Shares Bought by Wealthcare Advisory Partners LLC
Nova R Wealth Inc. Grows Stock Holdings in Amgen Inc. $AMGN - Stock Observer
Amgen's Repatha Data Reinforces Cardiovascular Franchise And Valuation Debate
REPATHA® CUTS RISK OF FIRST MAJOR CARDIOVASCULAR EVENTS BY 31% IN HIGH-RISK PATIENTS WITHOUT KNOWN SIGNIFICANT ATHEROSCLEROSIS
Clinical outcomes of third-line therapy for aGvHD with gastrointestinal involvement after steroids and ruxolitinib failure
Industry and academic leaders gather to accelerate new cancer cures
Dakota Wealth Management Acquires 4,581 Shares of Amgen Inc. $AMGN
Assessing Amgen (AMGN) Valuation As Shares Show Mixed Short And Long Term Returns
Gotistobart or docetaxel in metastatic squamous non-small cell lung cancer: stage 1 of the randomized phase 3 PRESERVE-003 trial
FY2027 EPS Estimates for Amgen Increased by Erste Group Bank
National Wealth Management Group LLC Invests $1.53 Million in Amgen Inc. $AMGN - Stock Observer
Wells Fargo Raises its Price Target on Amgen (AMGN) to $390 from $375
Pensionfund Sabic Makes New Investment in Amgen Inc. $AMGN
First-line Nivolumab plus FOLFOXIRI/Bevacizumab in advanced RAS/BRAF-mutated colorectal cancer: efficacy, safety and biomarker discovery from the phase II NIVACOR trial
Pembrolizumab and olaparib in homologous-recombination-deficient metastatic pancreatic cancer: the phase 2 POLAR trial
Assessing Amgen (AMGN) Valuation After Recent Share Price Pullback And Mixed Short Term Returns
10 Most Profitable S&P 500 Stocks to Buy Now
E. Ohman J or Asset Management AB Cuts Stock Holdings in Amgen Inc. $AMGN - Daily Political
Amgen Inc. $AMGN Shares Sold by E. Ohman J or Asset Management AB
Clear Trail Advisors LLC Takes Position in Amgen Inc. $AMGN
Avanza Fonder AB Increases Holdings in Amgen Inc. $AMGN
Gen Z and Millennial High-Net-Worth Investors Are Reshaping Wealth Advice
Flare of clonal hematopoiesis, TP53 expansion and prior melphalan drive post-CAR-T myeloid disorders in multiple myeloma
Enhanced dynamic risk stratification of smoldering multiple myeloma
Lilly, Amgen Seek Fast Win in Suit Over Clinics in Discount Plan
180 Wealth Advisors LLC Acquires 6,535 Shares of Amgen Inc. $AMGN
Wealth Enhancement Advisory Services LLC Trims Stake in Amgen Inc. $AMGN - Markets Daily
Amgen Inc. $AMGN Shares Sold by Sarasin & Partners LLP
Nordea Investment Management AB Sells 273,268 Shares of Amgen Inc. $AMGN - Stock Observer
Mixed feelings in Clare on potential Trump visit for Irish Open - 'It can disingenuous to target Doonbeg'
Mixed feelings in Clare on potential Trump visit for Irish Open - 'It can be disingenuous to target Doonbeg'
Promising Medical Stocks To Research - March 20th - Daily Political
Efficacy of stem cell boost (SCB) for chimeric antigen receptor-T cell therapy (CAR-T)-related hematologic toxicity in patients with relapsed/refractory multiple myeloma (RRMM)-real world experience from the US multiple myeloma immunotherapy consortium
Rocatinlimab Halt Puts Spotlight On Amgen Pipeline Risks And Valuation
Amgen (NASDAQ:AMGN) Given New $390.00 Price Target at Wells Fargo & Company
GAMMA Investing LLC Raises Stock Position in Amgen Inc. $AMGN
3,633 Shares in Amgen Inc. $AMGN Bought by Investment Research Partners LLC - Markets Daily
93,962 Shares in Amgen Inc. $AMGN Acquired by CIBC Bancorp USA Inc.
Amgen Inc. $AMGN Shares Purchased by AIA Group Ltd
Investment Research Partners LLC Invests $1.06 Million in Amgen Inc. $AMGN - Stock Observer
Amgen invested $407m in its Dún Laoghaire base over two years
Jacobs & Co. CA Has $14.26 Million Position in Amgen Inc. $AMGN - Daily Political
Type 2 diabetes mellitus
Amgen (AMGN) Valuation Check As Recent Share Momentum Cools
Amgen Inc. $AMGN Shares Sold by Avity Investment Management Inc.
Tcfg Wealth Management LLC Has $1.77 Million Stock Position in Amgen Inc. $AMGN - Stock Observer
Danske Bank A S Buys Shares of 358,171 Amgen Inc. $AMGN - Daily Political
Captrust Financial Advisors Has $137.07 Million Position in Amgen Inc. $AMGN - Daily Political
Amgen, GSK Set To Join TrumpRx Offering Deep Prescription Drug Discounts: Report
Amgen Inc. (AMGN): Billionaire Ken Fisher Doubles Bullish Position
How The Amgen (AMGN) Narrative Is Shifting With MariTide Hopes And Exclusivity Concerns
Amgen Inc. $AMGN Shares Purchased by Mariner LLC
6,457 Shares in Amgen Inc. $AMGN Acquired by Marshall Investment Management LLC - Markets Daily
Focus Partners Wealth Acquires 8,839 Shares of Amgen Inc. $AMGN
Amgen Inc. $AMGN Position Trimmed by CSM Advisors LLC
Alliancebernstein L.P. Sells 444,604 Shares of Amgen Inc. $AMGN
National Bank of Canada FI Acquires 863,216 Shares of Amgen Inc. $AMGN - Daily Political
Latest news
Show more
Global Market Review: Gold Volatility and Tech Stock Surge Amidst Economic Uncertainty
September CPI Data: Inflation Hurdles, Tariff Impacts, and Fed Rate Cut Expectations
Navigating the AI Boom: Strategies for Investors Amid Nvidia's Valuation Surge
